Vanguard Group »

Marker Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Marker Therapeutics (MRKR) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Marker Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Marker Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marker Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 225k 5.50
2023-09-30 $1.0M 221k 4.54
2023-06-30 $513k 166k 3.10
2023-03-31 $119k 167k 0.71